The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity.

Authors :: Liao WH
Yang GG
Henneberg M
Source :: Swiss medical weekly [Swiss Med Wkly] 2020 Dec 11; Vol. 150, pp. w20444. Date of Electronic Publication: 2020 Dec 11 (Print Publication: 2020).
Publication Year :: 2020

Subjects :: Acid-Base Equilibrium
Acidosis chemically induced
Acidosis metabolism
Angiotensin Receptor Antagonists therapeutic use
Angiotensin-Converting Enzyme 2 metabolism
Angiotensin-Converting Enzyme Inhibitors therapeutic use
CD4-Positive T-Lymphocytes immunology
COVID-19 metabolism
Cytokine Release Syndrome immunology
Glucocorticoids immunology
Glucocorticoids metabolism
Histocompatibility Antigens Class I immunology
Humans
Hypertension drug therapy
Killer Cells, Natural immunology
Natural Killer T-Cells immunology
Renal Elimination
Renin-Angiotensin System physiology
SARS-CoV-2 metabolism
T-Lymphocytes, Cytotoxic immunology
Acidosis immunology
Angiotensin Receptor Antagonists adverse effects
Angiotensin-Converting Enzyme Inhibitors adverse effects
COVID-19 immunology
Immunity, Cellular immunology
Pulmonary Ventilation
Renin-Angiotensin System immunology

Full Text Access

Tools